AKT1 and Behcet disease: While regulation of brain glucose metabolism has historically been regarded as largely insulin-independent, increasing evidence indicates that PI3K/Akt insulin signaling plays an important role in the hippocampus and cerebellum, and these brain regions have been identified as particularly vulnerable sites of gray matter loss in BD [82].